Real-time enrollment status for this pyoderma gangrenosum clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:21 AM UTC
| NCT Number | NCT06563323 |
| Recruiting Status | Recruiting |
| Condition | Pyoderma Gangrenosum |
| Phase | PHASE2 |
| Target Enrollment | 17 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Oregon Health and Science University |
| Last Updated on CT.gov | March 6, 2026 (Mar 6, 2026) |
As of July 17, 2026: Clinical trial NCT06563323 is currently recruiting participants. This phase2 study for pyoderma gangrenosum is actively seeking new participants at 2 locations across the United States. The study is sponsored by Oregon Health and Science University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06563323 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06563323 was last updated Mar 6, 2026 (March 6, 2026). HelloStudys verifies this status automatically.